GLP-1R Agonist Pharmaceutical Composition and Uses

Abstract

GLP-1R agonist pharmaceutical compositions and uses thereof are disclosed. The pharmaceutical compositions include the compound represented by formula I or a pharmaceutically acceptable salt thereof, as an active ingredient. The pharmaceutical compositions include an acid-fast compound, and can release the active ingredient in the pharmaceutical composition slowly, thereby reducing in vivo absorption side effects following GLP-1R administration.